Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram versus placebo added to naltrexone for alcohol dependence with major depression
ACTRN12606000413527Phase 2Not yet recruiting
- Sponsor
- Professor Doug Sellman
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of citalopram and naltrexone in alcohol dependence and major depressive disorder (MDD) (2 arms), sponsored by Professor Doug Sellman. Primary endpoints: Percent days abstinent and Montgomery and Asberg Depression Rating Scale (MADRS) score. Planned start Oct 2006; status: not yet recruiting.
02
Drugs
citalopramnaltrexone
03
Conditions
alcohol dependencemajor depressive disorder (MDD)
Beyond the preview
Go deeper on ACTRN12606000413527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000413527.